Toll-like receptor 4 deficiency: Smaller infarcts, but nogain in function

Se Chan Kim1, Alexander Ghanem2, Heidi Stapel3, Klaus Tiemann2, Pascal Knuefermann1, Andreas Hoeft1, Rainer Meyer3, Christian Grohé2, Anne A Knowlton4, Georg Baumgarten1
1Department of Anesthesiology and Intensive Care Medicine, University of Bonn, Germany;
2Department of Internal Medicine, University of Bonn, Germany
3Institute of Physiology, University of Bonn, Germany
4Division of Cardiovascular Medicine, University of California, Davis, USA

Tóm tắt

Abstract Backgound It has been reported that Toll-like receptor 4 (TLR4) deficiency reduces infarct size after myocardial ischemia/reperfusion (MI/R). However, measurement of MI/R injury was limited and did not include cardiac function. In a chronic closed-chest model we assessed whether cardiac function is preserved in TLR4-deficient mice (C3H/HeJ) following MI/R, and whether myocardial and systemic cytokine expression differed compared to wild type (WT). Results Infarct size (IS) in C3H/HeJ assessed by TTC staining after 60 min ischemia and 24h reperfusion was significantly smaller than in WT. Despite a smaller infarct size, echocardiography showed no functional difference between C3H/HeJ and WT. Left-ventricular developed pressure measured with a left-ventricular catheter was lower in C3H/HeJ (63.0 ± 4.2 mmHg vs. 77.9 ± 1.7 mmHg in WT, p < 0.05). Serum cytokine levels and myocardial IL-6 were higher in WT than in C3H/HeJ (p < 0.05). C3H/HeJ MI/R showed increased myocardial IL-1β and IL-6 expression compared to their respective shams (p < 0.05), indicating TLR4-independent cytokine activation due to MI/R. Conclusion These results demonstrate that, although a mutant TLR4 signaling cascade reduces myocardial IS and serum cytokine levels, it does not preserve myocardial function. The change in inflammatory response, secondary to a non-functional TLR-4 receptor, may contribute to the observed dichotomy between infarct size and function in the TLR-4 mutant mouse.

Từ khóa


Tài liệu tham khảo

Medzhitov R, Preston-Hurlburt P, Janeway CA: A human homologue of the Drosophila Toll protein signals activation of adaptive immunity1080. Nature. 1997, 388: 394-397. 10.1038/41131.

Schulz R, Aker S, Belosjorow S, Heusch G: TNFalpha in ischemia/reperfusion injury and heart failure. Basic Res Cardiol. 2004, 99: 8-11. 10.1007/s00395-003-0431-x.

Poltorak A, He X, Smirnova I, Liu MY, Huffel CV, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B: Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene1018. Science. 1998, 282: 2085-2088. 10.1126/science.282.5396.2085.

Ohashi K, Burkart V, Flohe S, Kolb H: Cutting Edge: Heat Shock Protein 60 Is a Putative Endogenous Ligand of the Toll-Like Receptor-4 Complex1028. J Immunol. 2000, 164: 558-561.

Okamura Y, Watari M, Jerud ES, Young DW, Ishizaka ST, Rose J, Chow JC, Strauss JF: The Extra Domain A of Fibronectin Activates Toll-like Receptor 41072. J Biol Chem. 2001, 276: 10229-10233. 10.1074/jbc.M100099200.

Vink A, Schoneveld AH, van der Meer JJ, van Middelaar BJ, Sluijter JPG, Smeets MB, Quax PHA, Lim SK, Borst C, Pasterkamp G, de Kleijn DPV: In Vivo Evidence for a Role of Toll-Like Receptor 4 in the Development of Intimal Lesions1073. Circulation. 2002, 106: 1985-1990. 10.1161/01.CIR.0000032146.75113.EE.

Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, Ahrens T, Miyake K, Freudenberg M, Galanos C, Simon JC: Oligosaccharides of Hyaluronan Activate Dendritic Cells via Toll-like Receptor 41075. J Exp Med. 2002, 195: 99-111. 10.1084/jem.20001858.

Oyama J, Blais C, Liu X, Pu M, Kobzik L, Kelly RA, Bourcier T: Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice. Circulation. 2004, 109: 784-789. 10.1161/01.CIR.0000112575.66565.84.

Chong AJ, Shimamoto A, Hampton CR, Takayama H, Spring DJ, Rothnie CL, Yada M, Pohlman TH, Verrier ED: Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart. J Thorac Cardiovasc Surg. 2004, 128: 170-179. 10.1016/j.jtcvs.2003.11.036.

Zhu X, Zhao H, Graveline AR, Buys ES, Schmidt U, Bloch KD, Rosenzweig A, Chao W: MyD88 and NOS2 are essential for Toll-like receptor 4-mediated survival effect in cardiomyocytes. Am J Physiol Heart Circ Physiol. 2006, 291: H1900-H1909. 10.1152/ajpheart.00112.2006.

Chao W, Shen Y, Zhu X, Zhao H, Novikov M, Schmidt U, Rosenzweig A: Lipopolysaccharide Improves Cardiomyocyte Survival and Function after Serum Deprivation. J Biol Chem. 2005, 280: 21997-22005. 10.1074/jbc.M413676200.

Brown JM, Grosso MA, Terada LS, Whitman GJ, Banerjee A, White CW, Harken AH, Repine JE: Endotoxin pretreatment increases endogenous myocardial catalase activity and decreases ischemia-reperfusion injury of isolated rat hearts. Proc Natl Acad Sci U S A. 1989, 86: 2516-2520. 10.1073/pnas.86.7.2516.

Meng X, Ao L, Brown JM, Meldrum DR, Sheridan BC, Cain BS, Banerjee A, Harken AH: LPS induces late cardiac functional protection against ischemia independent of cardiac and circulating TNF-alpha. Am J Physiol. 1997, 273: H1894-H1902.

Vogel WM, Cerel AW, Apstein CS: Post-ischemic cardiac chamber stiffness and coronary vasomotion: the role of edema and effects of dextran. J Mol Cell Cardiol. 1986, 18: 1207-1218. 10.1016/S0022-2828(86)80425-4.

Belosjorow S, Schulz R, Dorge H, Schade FU, Heusch G: Endotoxin and ischemic preconditioning: TNF-alpha concentration and myocardial infarct development in rabbits. Am J Physiol. 1999, 277: H2470-H2475.

Hiasa G, Hamada M, Ikeda S, Hiwada K: Ischemic preconditioning and lipopolysaccharide attenuate nuclear factor-kappaB activation and gene expression of inflammatory cytokines in the ischemia-reperfused rat heart. Jpn Circ J. 2001, 65: 984-990. 10.1253/jcj.65.984.

Zacharowski K, Otto M, Hafner G, Chatterjee PK, Thiemermann C: Endotoxin induces a second window of protection in the rat heart as determined by using p-nitro-blue tetrazolium staining, cardiac troponin T release, and histology14. Arterioscler Thromb Vasc Biol. 1999, 19: 2276-2280.

Baumgarten G, Knuefermann P, Schuhmacher G, Vervolgyi V, von RJ, Dreiner U, Fink K, Djoufack C, Hoeft A, Grohe C, Knowlton AA, Meyer R: TOLL-LIKE RECEPTOR 4, NITRIC OXIDE, AND MYOCARDIAL DEPRESSION IN ENDOTOXEMIA. Shock. 2006, 25: 43-49. 10.1097/01.shk.0000196498.57306.a6.

Baumgarten G, Knuefermann P, Nozaki N, Sivasubramanian N, Mann DL, Vallejo JG: In vivo expression of proinflammatory mediators in the adult heart after endotoxin administration: the role of toll-like receptor-4. J Infect Dis. 2001, 183: 1617-1624. 10.1086/320712.

Knuefermann P, Nemoto S, Baumgarten G, Misra A, Sivasubramanian N, Carabello BA, Vallejo JG: Cardiac Inflammation and Innate Immunity in Septic Shock* : Is There a Role for Toll-Like Receptors?. Chest. 2002, 121: 1329-1336. 10.1378/chest.121.4.1329.

Nemoto S, Vallejo JG, Knuefermann P, Misra A, Defreitas G, Carabello BA, Mann DL: Escherichia coli LPS-induced LV dysfunction: role of toll-like receptor-4 in the adult heart1025. Am J Physiol Heart Circ Physiol. 2002, 282: H2316-H2323.

Nossuli TO, Lakshminarayanan V, Baumgarten G, Taffet GE, Ballantyne CM, Michael LH, Entman ML: A chronic mouse model of myocardial ischemia-reperfusion: essential in cytokine studies52. Am J Physiol Heart Circ Physiol. 2000, 278: H1049-H1055.

Guo Y, Wu WJ, Qiu Y, Tang XL, Yang Z, Bolli R: Demonstration of an early and a late phase of ischemic preconditioning in mice. Am J Physiol. 1998, 275: H1375-H1387.

Kapadia SR, Oral H, Lee J, Nakano M, Taffet GE, Mann DL: Hemodynamic Regulation of Tumor Necrosis Factor-{alpha} Gene and Protein Expression in Adult Feline Myocardium. Circ Res. 1997, 81: 187-195.

Nian M, Lee P, Khaper N, Liu P: Inflammatory Cytokines and Postmyocardial Infarction Remodeling. Circ Res. 2004, 94: 1543-1553. 10.1161/01.RES.0000130526.20854.fa.

Sugishita K, Kinugawa K, Shimizu T, Harada K, Matsui H, Takahashi T, Serizawa T, Kohmoto O: Cellular basis for the acute inhibitory effects of IL-6 and TNF- alpha on excitation-contraction coupling. J Mol Cell Cardiol. 1999, 31: 1457-1467. 10.1006/jmcc.1999.0989.

Tatsumi T, Matoba S, Kawahara A, Keira N, Shiraishi J, Akashi K, Kobara M, Tanaka T, Katamura M, Nakagawa C: Cytokine-induced nitric oxide production inhibits mitochondrial energy production and impairs contractile function in rat cardiac myocytes. Journal of the American College of Cardiology. 2000, 35: 1338-1346. 10.1016/S0735-1097(00)00526-X.

Deten A, Volz HC, Briest W, Zimmer HG: Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental studies in rats. Cardiovasc Res. 2002, 55: 329-340. 10.1016/S0008-6363(02)00413-3.

Wollert KC, Drexler H: The role of interleukin-6 in the failing heart. Heart Fail Rev. 2001, 6: 95-103. 10.1023/A:1011401825680.

Dewald O, Zymek P, Winkelmann K, Koerting A, Ren G, bou-Khamis T, Michael LH, Rollins BJ, Entman ML, Frangogiannis NG: CCL2/Monocyte Chemoattractant Protein-1 Regulates Inflammatory Responses Critical to Healing Myocardial Infarcts. Circ Res. 2005, 96: 881-889. 10.1161/01.RES.0000163017.13772.3a.

Streif JU, Nahrendorf M, Hiller KH, Waller C, Wiesmann F, Rommel E, Haase A, Bauer WR: In vivo assessment of absolute perfusion and intracapillary blood volume in the murine myocardium by spin labeling magnetic resonance imaging. Magn Reson Med. 2005, 53: 584-592. 10.1002/mrm.20327.

Kurrelmeyer KM, Michael LH, Baumgarten G, Taffet GE, Peschon JJ, Sivasubramanian N, Entman ML, Mann DL: Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. Proc Natl Acad Sci U S A. 2000, 97: 5456-5461. 10.1073/pnas.070036297.

Roell W, Lu ZJ, Bloch W, Siedner S, Tiemann K, Xia Y, Stoecker E, Fleischmann M, Bohlen H, Stehle R, Kolossov E, Brem G, Addicks K, Pfitzer G, Welz A, Hescheler J, Fleischmann BK: Cellular Cardiomyoplasty Improves Survival After Myocardial Injury186. Circulation. 2002, 105: 2435-2441. 10.1161/01.CIR.0000016063.66513.BB.

Dawson D, Lygate CA, Saunders J, Schneider JE, Ye X, Hulbert K, Noble JA, Neubauer S: Quantitative 3-Dimensional Echocardiography for Accurate and Rapid Cardiac Phenotype Characterization in Mice. Circulation. 2004, 110: 1632-1637. 10.1161/01.CIR.0000142049.14227.AD.